首页> 外文期刊>Journal of Cancer Research and Practice >Chemotherapy plus nivolumab-associated acute kidney injury in a patient with non-oropharyngeal head and neck squamous cell carcinoma with renal metastasis
【24h】

Chemotherapy plus nivolumab-associated acute kidney injury in a patient with non-oropharyngeal head and neck squamous cell carcinoma with renal metastasis

机译:非咽喉头颈鳞状细胞癌伴肾转移的患者的化学疗法加尼古拉单抗相关的急性肾损伤

获取原文
           

摘要

The frequency of immunotherapy-associated acute kidney injury is low, and the incidence of head and neck squamous cell carcinoma metastasizing to the kidney is even lower. We report a 52-year-old man with both conditions who experienced acute kidney injury after receiving treatment with chemotherapy plus immunotherapy including ifosfamide, etoposide, and nivolumab. Following steroid treatment, his serum creatinine level partially recovered to near baseline level. To the best of our knowledge, this is the first such case to be reported in the literature. Chemotherapy plus immunotherapy should be used with caution.
机译:免疫疗法引起的急性肾脏损伤的频率较低,头颈部鳞状细胞癌转移至肾脏的发生率更低。我们报告了一名52岁的男性,有两种情况,在接受化学疗法加免疫疗法(包括异环磷酰胺,依托泊苷和nivolumab)治疗后均经历了急性肾损伤。类固醇治疗后,他的血清肌酐水平部分恢复至基线水平。据我们所知,这是文献中首次报道这种情况。应谨慎使用化学疗法加免疫疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号